FENNEC PHARMACEUTICALS INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.0M | $-2.8M | $-659.0K | $-2.2M | $1.8M | $-5.2M | $4.7M | $-7.8M |
| Depreciation & Amortization | — | — | — | — | $0 | $0 | $0 | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.5M | $615.0K | $97.0K | $627.0K | $62.0K | $174.0K | $129.0K | $2.4M |
| Net Cash from Operating Activities | $-3.6M | $-2.1M | $-1.9M | $-1.7M | $-2.2M | $-3.0M | $-3.2M | $-1.9M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | $0 | $0 | $0 | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $0 | — | $0 | $0 | $0 | $0 | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $28.0M | $5.1M | — | $2.3M | $1.6M | $0 | $2.6M | $7.2M |
| Net Change in Cash | $24.3M | $3.0M | $-1.4M | $644.0K | $-640.0K | $-3.0M | $-650.0K | $5.3M |
| Free Cash Flow | — | — | — | — | $-2.2M | $-3.0M | $-3.2M | — |